메뉴 건너뛰기




Volumn 23, Issue 1, 2006, Pages 107-130

Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies

Author keywords

Exercise testing; Molsidomine; Once daily formulation; Stable angina

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CORUNO; CORVATARD; GEOMATRIX; ISOSORBIDE DINITRATE; MOLSIDOMINE; NITRIC ACID DERIVATIVE; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT;

EID: 33646148464     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850352     Document Type: Article
Times cited : (8)

References (33)
  • 1
    • 0035056817 scopus 로고    scopus 로고
    • Contemporary management of chronic stable angina
    • Staniforth AD. Contemporary management of chronic stable angina. Drugs Aging. 2001;18:109-121.
    • (2001) Drugs Aging , vol.18 , pp. 109-121
    • Staniforth, A.D.1
  • 3
    • 0035217109 scopus 로고    scopus 로고
    • A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina
    • Hall R, Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina. Cardiology. 2001;96:72-77.
    • (2001) Cardiology , vol.96 , pp. 72-77
    • Hall, R.1    Chong, C.2
  • 4
    • 0028365339 scopus 로고
    • Phenomenon of nitrate tolerance
    • Mangione NJ, Glasser SP. Phenomenon of nitrate tolerance. Am Heart J. 1994;128:137-146.
    • (1994) Am Heart J , vol.128 , pp. 137-146
    • Mangione, N.J.1    Glasser, S.P.2
  • 5
    • 0037012370 scopus 로고    scopus 로고
    • The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy
    • Parker JO, Parker JD, Caldwell RW, Farrell B, Kaesemeyer WH. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J Am Coll Cardiol. 2002;39:1199-1203.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1199-1203
    • Parker, J.O.1    Parker, J.D.2    Caldwell, R.W.3    Farrell, B.4    Kaesemeyer, W.H.5
  • 6
    • 11144354818 scopus 로고    scopus 로고
    • Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance
    • Sydow K, Daiber A, Oelze M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest. 2004;113:482-489.
    • (2004) J Clin Invest , vol.113 , pp. 482-489
    • Sydow, K.1    Daiber, A.2    Oelze, M.3
  • 7
    • 4143128926 scopus 로고    scopus 로고
    • Contemporary management of silent ischemia: The role of ambulatory monitoring
    • Solomon H, DeBusk RF. Contemporary management of silent ischemia: the role of ambulatory monitoring. Int J Cardiol. 2004;96:311-319.
    • (2004) Int J Cardiol , vol.96 , pp. 311-319
    • Solomon, H.1    DeBusk, R.F.2
  • 9
    • 0028103963 scopus 로고
    • Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration
    • Hug J, Hasenfuss G, Wollschlager H, Just HJ, Bonzel T. Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration. Med Klin. 1994;89(suppl 2):34-37.
    • (1994) Med Klin , vol.89 , Issue.SUPPL. 2 , pp. 34-37
    • Hug, J.1    Hasenfuss, G.2    Wollschlager, H.3    Just, H.J.4    Bonzel, T.5
  • 10
    • 0028132726 scopus 로고
    • Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease
    • Münzel T, Kurz S, Heitzer T, Luhmann C, Just HJ. Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease. Med Klin. 1994;89(suppl 2):38-41.
    • (1994) Med Klin , vol.89 , Issue.SUPPL. 2 , pp. 38-41
    • Münzel, T.1    Kurz, S.2    Heitzer, T.3    Luhmann, C.4    Just, H.J.5
  • 12
    • 0023505509 scopus 로고
    • Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
    • Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
    • (1987) Proc Natl Acad Sci USA , vol.84 , pp. 9265-9269
    • Ignarro, L.J.1    Buga, G.M.2    Wood, K.S.3    Byrns, R.E.4    Chaudhuri, G.5
  • 13
    • 0024796728 scopus 로고
    • On the mechanism of NO release from sydnonimines
    • Feelisch M, Ostrowski J, Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol. 1989;14(suppl 11):S13-S22.
    • (1989) J Cardiovasc Pharmacol , vol.14 , Issue.SUPPL. 11
    • Feelisch, M.1    Ostrowski, J.2    Noack, E.3
  • 14
    • 0024799327 scopus 로고
    • Molsidomine is a donor of EDRF
    • Vanhoutte PM. Molsidomine is a donor of EDRF. J Cardiovasc Pharmacol. 1989;14(suppl 11):S139-S140.
    • (1989) J Cardiovasc Pharmacol , vol.14 , Issue.SUPPL. 11
    • Vanhoutte, P.M.1
  • 15
    • 0027458533 scopus 로고
    • SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty
    • Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation. 1993;87:590-597.
    • (1993) Circulation , vol.87 , pp. 590-597
    • Groves, P.H.1    Lewis, M.J.2    Cheadle, H.A.3    Penny, W.J.4
  • 16
    • 0034059722 scopus 로고    scopus 로고
    • 2+ handling in patients with suspected coronary artery disease: Ex vivo and in vitro studies
    • 2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies. Thromb Haemost. 2000;83:752-758.
    • (2000) Thromb Haemost , vol.83 , pp. 752-758
    • Le Quan Sang, K.H.1    Le Feuvre, C.2    Brunet, A.3
  • 17
    • 0022196041 scopus 로고
    • Exercise tolerance in coronary patients: Randomized trial of two-week treatment with molsidomine versus placebo
    • Messin R. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo. Am Heart J. 1985;109:667-669.
    • (1985) Am Heart J , vol.109 , pp. 667-669
    • Messin, R.1
  • 18
    • 0028919862 scopus 로고
    • Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina: A double-blind cross-over clinical trial versus placebo
    • Messin R, Boxho G, De Smedt J, Buntinx IM. Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina: a double-blind cross-over clinical trial versus placebo. J Cardiovasc Pharmacol. 1995;25:558-563.
    • (1995) J Cardiovasc Pharmacol , vol.25 , pp. 558-563
    • Messin, R.1    Boxho, G.2    De Smedt, J.3    Buntinx, I.M.4
  • 19
    • 0031911443 scopus 로고    scopus 로고
    • Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: A multicenter randomized double-blind crossover placebo-controlled trial
    • Messin R, Karpov Y, Baikova N, et al. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial. J Cardiovasc Pharmacol. 1998;31:271-276.
    • (1998) J Cardiovasc Pharmacol , vol.31 , pp. 271-276
    • Messin, R.1    Karpov, Y.2    Baikova, N.3
  • 21
    • 0021680630 scopus 로고
    • Effect duration and dose-response relation of molsidomine in patients with coronary heart disease
    • Fach WA, Becker HJ. Effect duration and dose-response relation of molsidomine in patients with coronary heart disease. Z Kardiol. 1984;73:613-622.
    • (1984) Z Kardiol , vol.73 , pp. 613-622
    • Fach, W.A.1    Becker, H.J.2
  • 22
    • 0030152638 scopus 로고    scopus 로고
    • Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility
    • Conte U, Maggi L. Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 1996;17:889-896.
    • (1996) Biomaterials , vol.17 , pp. 889-896
    • Conte, U.1    Maggi, L.2
  • 23
    • 0033952741 scopus 로고    scopus 로고
    • High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms
    • Maggi L, Bruni R, Conte U. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm. 2000;195:229-238.
    • (2000) Int J Pharm , vol.195 , pp. 229-238
    • Maggi, L.1    Bruni, R.2    Conte, U.3
  • 24
    • 3242802152 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of once-daily molsidomine: From immediate-release to prolonged-release once-daily formulations
    • Herchuelz A, Carreer-Bruhwyler F, Crommen J, et al. Clinical pharmacokinetics of once-daily molsidomine: from immediate-release to prolonged-release once-daily formulations. Am J Drug Deliv. 2004;131-141.
    • (2004) Am J Drug Deliv , pp. 131-141
    • Herchuelz, A.1    Carreer-Bruhwyler, F.2    Crommen, J.3
  • 25
    • 0031726089 scopus 로고    scopus 로고
    • A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris
    • van Kesteren HA, Withagen AJ. A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Cardiovasc Drugs Ther. 1998;12(suppl 3):233-237.
    • (1998) Cardiovasc Drugs Ther , vol.12 , Issue.SUPPL. 3 , pp. 233-237
    • Van Kesteren, H.A.1    Withagen, A.J.2
  • 26
    • 0033639013 scopus 로고    scopus 로고
    • Factors influencing efficacy of nitrate therapy for stable angina pectoris: A multiple linear regression analysis
    • Jansen R, Niemeyer MG, Cleophas TJ, Zwinderman AH. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis. Angiology. 2000;51:1007-1012.
    • (2000) Angiology , vol.51 , pp. 1007-1012
    • Jansen, R.1    Niemeyer, M.G.2    Cleophas, T.J.3    Zwinderman, A.H.4
  • 27
    • 0034882896 scopus 로고    scopus 로고
    • A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina
    • Chugh SK, Digpal K, Hutchinson T, McDonald CJ, Miller AJ, Lahiri A. A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina. J Cardiovasc Pharmacol. 2001;38:356-364.
    • (2001) J Cardiovasc Pharmacol , vol.38 , pp. 356-364
    • Chugh, S.K.1    Digpal, K.2    Hutchinson, T.3    McDonald, C.J.4    Miller, A.J.5    Lahiri, A.6
  • 28
    • 0035094582 scopus 로고    scopus 로고
    • Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART)
    • Spertus JA, Dewhurst T, Dougherty CM, Nichol P. Testing the effectiveness of converting patients to long-acting antianginal medications: the Quality of Life in Angina Research Trial (QUART). Am Heart J. 2001;141:550-558.
    • (2001) Am Heart J , vol.141 , pp. 550-558
    • Spertus, J.A.1    Dewhurst, T.2    Dougherty, C.M.3    Nichol, P.4
  • 29
    • 0015058704 scopus 로고
    • Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris
    • Redwood DR, Rosing DR, Goldstein RE, Beiser GD, Epstein SE. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation. 1971;43:618-628.
    • (1971) Circulation , vol.43 , pp. 618-628
    • Redwood, D.R.1    Rosing, D.R.2    Goldstein, R.E.3    Beiser, G.D.4    Epstein, S.E.5
  • 31
    • 0024294261 scopus 로고
    • Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis
    • Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med. 1988;84(suppl 2A):20-24.
    • (1988) Am J Med , vol.84 , Issue.SUPPL. 2A , pp. 20-24
    • Bloom, B.S.1
  • 32
    • 0031659477 scopus 로고    scopus 로고
    • Continuation of initial antihypertensive medication after 1 year of therapy
    • Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:1-11.
    • (1998) Clin Ther , vol.20 , pp. 1-11
    • Bloom, B.S.1
  • 33
    • 0035934617 scopus 로고    scopus 로고
    • Daily regimen and compliance with treatment
    • Bloom BS. Daily regimen and compliance with treatment. BMJ. 2001;323:647.
    • (2001) BMJ , vol.323 , pp. 647
    • Bloom, B.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.